1. Chang, Jingjia, Wu, Hao, Wu, Jin, Yu, Pengfei, Zhu, Jianjun. 2023. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma. In Journal of translational medicine, 21, 191. doi:10.1186/s12967-023-04033-6. https://pubmed.ncbi.nlm.nih.gov/36915111/
2. Udhaya Kumar, S, Thirumal Kumar, D, Mandal, Pinky D, George Priya Doss, C, Zayed, Hatem. 2020. Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene. In Advances in protein chemistry and structural biology, 120, 349-377. doi:10.1016/bs.apcsb.2019.11.004. https://pubmed.ncbi.nlm.nih.gov/32085885/
3. Dong, Hao, He, Linsheng, Sun, Qiran, Yin, Chen, He, Quan. 2023. Inhibit ALDH3A2 reduce ovarian cancer cells survival via elevating ferroptosis sensitivity. In Gene, 876, 147515. doi:10.1016/j.gene.2023.147515. https://pubmed.ncbi.nlm.nih.gov/37247796/
4. Lv, Qingyang, Shi, Jian, Miao, Daojia, Xiong, Zhiyong, Zhang, Xiaoping. 2023. miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway. In Translational oncology, 40, 101835. doi:10.1016/j.tranon.2023.101835. https://pubmed.ncbi.nlm.nih.gov/38039946/